Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Indoor Air. 2012 Nov 23;23(4):268–274. doi: 10.1111/ina.12009

Table 2.

Asthma Characteristics at Baseline

mean±SD
FEV1, % predicted* 93.5±18.5
FVC, % predicted* 99.7±15.8
FEV1/FVC %* 80.9±9.9
Days of symptoms/2 weeks 4.9±4.8
Days of short-acting beta agonist use/2 weeks 4.2±5.0
Controller medication, n (%) 108 (72)
FENO (ppb), median (25th%–75th%) 33 (16–62)
*

n=140